Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR

Priya Murugesan,Yixuan Zhang,Yuanli Huang,Nobel Chengong Zong,Ji Youn Youn,Wenhui Chen,Chen Wang,Joseph Loscalzo,Hua Cai
DOI: https://doi.org/10.1161/circresaha.123.323090
IF: 23.213
2024-02-03
Circulation Research
Abstract:Circulation Research, Ahead of Print. BACKGROUND:Pulmonary hypertension (PH) is a progressive disorder characterized by remodeling of the pulmonary vasculature and elevated mean pulmonary arterial pressure, resulting in right heart failure.METHODS:Here, we show that direct targeting of the endothelium to eNOS (endothelial nitric oxide synthase) with DAHP (2,4-diamino 6-hydroxypyrimidine; an inhibitor of GTP cyclohydrolase 1, the rate-limiting synthetic enzyme for the critical eNOS cofactor tetrahydrobiopterin) induces human-like, time-dependent progression of PH phenotypes in mice.RESULTS:Critical phenotypic features include elevation in mean pulmonary arterial pressure, right ventricular systolic blood pressure, and right ventricular/(LV+S) ratio; extensive vascular remodeling of pulmonary arterioles with increased medial thickness/perivascular collagen deposition and increased expression of PCNA (proliferative cell nuclear antigen) and alpha-actin; increased total and mitochondrial superoxide production, reduced tetrahydrobiopterin, and nitric oxide bioavailabilities; and formation of an array of human-like vascular lesions. Intriguingly, novel in-house generated endothelial-specific dihydrofolate reductase (DHFR) transgenic mice were completely protected from the pathophysiological and molecular features of PH upon DAHP treatment or hypoxia. Furthermore, DHFR overexpression with a pCMV-DHFR plasmid transfection in mice after initiation of DAHP treatment completely reversed PH phenotypes. DHFR knockout mice spontaneously developed PH at baseline and had no additional deterioration in response to hypoxia, indicating an intrinsic role of DHFR deficiency in causing PH. RNA-sequencing experiments indicated great similarity in gene regulation profiles between the DAHP model and patients with human PH.Conclusions:Taken together, these results establish a novel human-like murine model of PH that has long been lacking in the field, which can be broadly used for future mechanistic and translational studies. These data also indicate that targeting endothelial DHFR deficiency represents a novel and robust therapeutic strategy for the treatment of PH.
cardiac & cardiovascular systems,peripheral vascular disease,hematology
What problem does this paper attempt to address?